stroke

Pharma

Amgen's Repatha meets the mark in CV primary prevention trial

On the heels of a label expansion in August, Amgen is touting another potential avenue to extend the value of its aging PCSK9 cholesterol med Repatha.

Fraiser Kansteiner Oct 2, 2025 11:26am

FDA approves Roche's heart attack med TNKase to treat stroke

Mar 3, 2025 3:19pm

FDA approves Agepha’s version of colchicine for heart disease

Jun 20, 2023 8:10am

Nasal delivery gets antibody to rodent brains to treat stroke

Jan 24, 2023 6:40am

J&J-Legend, Junshi, Vir-WuXi and more—Fierce Pharma Asia

May 27, 2022 9:53am

ACC: Lexicon's sotagliflozin can cut stroke, heart attack

Apr 2, 2022 3:37pm